http://www.fpnotebook.com/
Alopecia AreataAka: Exclamation Point Hair
- Definition
- Non-scarring autoimmune Alopecia
- Epidemiology
- No gender predominance
- Most common under age 30
- Prevalence: 0.1 - 0.2% of U.S. population
- Types
- Alopecia areata: Patches of Hair Loss
- Alopecia totalis: Hair Loss over entire scalp
- Alopecia universalis: Hair Loss over entire body
- Signs
- Well-demarcated oval patches of Hair Loss
- Exclamation point hairs at edges of Hair Loss
- Club shaped Hair Root
- Thin proximal Hair Shaft
- Normal caliber distal Hair Shaft
- Lab Evaluation (Consider)
- KOH Scraping of patch
- Thyroid Stimulating Hormone (TSH)
- Rapid Plasma Reagin (RPR)
- Erythrocyte Sedimentation Rate (ESR)
- Complete Blood Count (CBC)
- Antinuclear Antibody (ANA)
- Rheumatoid Factor (RF)
- Differential Diagnosis
- Other non-scarring Alopecia
- Tinea Capitis
- Associated Conditions
- Atopic Dermatitis
- Vitiligo
- Thyroid disease
- Pernicious Anemia
- Management: Moderate Involvement (<50% of scalp involved)
- Intralesional Kenalog
- Treatment of choice
- Dilute kenalog 40 mg/ml with saline to 10 mg/ml
- Kenalog 40 mg/ml: 0.5 ml
- Saline: 2 ml
- Inject 0.1 ml into patch at 1 cm intervals
- Inject into mid-Dermis via 0.5 inch needle
- Adverse effects: Atrophy
- Avoid injecting too superficially
- Avoid injecting >0.1 ml or >10 mg/ml per site
- Limit injections to no more often than q4-6 weeks
- Discontinue if no improvement at 6 months
- Adjuncts to intralesional injection
- Apply Minoxidil 5% solution twice daily or
- Mid-potency Topical Corticosteroid (eg. Kenalog 0.1%)
- Apply 1 ml to entire scalp twice daily
- Management: Severe Involvement (>50% of scalp involved)
- General: Combination therapy often used
- Contact sensitizers with intralesional kenalog
- Most effective option
- Usually requires referral to dermatology
- Minoxidil 5% bid with Topical Steroids or Anthralin
- Topical Anthralin Cream (Psoriatec) 0.1 to 1% cream
- Course usually limited to 6 months
- Apply daily and leave on for 5 minutes to start
- Gradually increase time applied up to 60 minutes
- Rinse scalp well and then clean with soap
- New Hair Growth seen within 3 months
- Mid-potency Topical Corticosteroid (eg. Kenalog 0.1%)
- Apply 1 ml to entire scalp twice daily
- Topical Minoxidil 5%
- Use as adjunct to Anthralin or Corticosteroid
- Prednisone (less commonly used)
- Start: 40 mg PO qd for 7 days
- Taper: Decrease by 5 mg q3 days
- Course completed within 6 weeks
- Dermatology consultation for contact sensitizer
- Dinitrochlorobenzene
- Diphenylcyclopropenone
- Squaric acid dibutyl ester
- Course
- Spontaneously resolves in 6-12 months in most cases
- Hair pigmentation may be different in regrowth area
- Some cases progress (see prognostic indicators below)
- Recurs in 30% of cases (often affects same area)
- Prognosis: Indicators of poor prognosis
- Course duration longer than one year
- Onset of Alopecia prior to Puberty
- Family History of Alopecia areata
- Atopic Patients
- Down Syndrome
- References
- Bertolino (2000) Postgrad Med 107(7):81
- Madani (2000) J Am Acad Dermatol 42:549
- Springer (2003) Am Fam Physician 68(1):93
- Thiedke (2003) Am Fam Physician 67(5):1007
Alopecia Areata (C0002171)
|
|---|
| Definition (MSH) | A microscopically inflammatory, usually reversible, patchy hair loss occurring in sharply defined areas and usually involving the beard or scalp. (Dorland, 27th ed) |
| Concepts | Disease or Syndrome (T047)
|
| ICD9 | 704.01 |
| English | Alopecia Areata, Alopecia circumscripta, Circumscribed alopecia, Patchy loss of hair |
| Spanish | alopecia areata, alopecia circunscripta, pérdida de pelo en placas, perdida de pelo en placas |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree